Drug Type Small molecule drug |
Synonyms Compound 21b(Hyundai) |
Target |
Action agonists |
Mechanism GPR119 agonists(Glucose-dependent insulinotropic receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC30H40N4O3 |
InChIKeyVVOHWUFMNGRYMK-RRPNLBNLSA-N |
CAS Registry2097502-14-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Preclinical | South Korea | 24 Jan 2025 | |
Obesity | Preclinical | South Korea | 24 Jan 2025 |